Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized placebo-controlled double blind study to prevent BOS after lung transplantation
2010-022027-30Phase 4Completed
- Sponsor
- UZ Leuven
- Start
- Sep 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in chronic lung allograft dysfunction (CLAD), Bronchiolitis Obliterans (BO) and Bronchiolitis Obliterans Syndrome (BOS) comparing Colecalciferol (D-cure) with Placebo (2 arms). Primary endpoint: Development of chronic rejection (bronchiolitis obliterans syndrome). Started Sep 2010; status: completed.
02
Drugs
cholecalciferol
03
Conditions
chronic lung allograft dysfunction (CLAD)Bronchiolitis Obliterans (BO)Bronchiolitis Obliterans Syndrome (BOS)
Beyond the preview
Go deeper on 2010-022027-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-022027-30.